The commonly used tumor markers for GC patients in our hospital include carbohydrate antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA). The gene discussed is CEACAM5; the disease is neoplasm.